Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'bax inhibitor peptide negative control'

Search results for: 'bax inhibitor peptide negative control'

Items 31-40 of 97

Page
per page
  1. GW2580
    A1655 GW2580
     1 Citation
    Target: CSF-1R
    Summary: CFMS kinase/CSF-1R inhibitor,selective and ATP-competitive
      ≥36.6 mg/mL
  2. CO-1686 (AVL-301)
    A3320 CO-1686 (AVL-301)
     1 Citation
    Target: EGFR
    Summary: EGFR inhibitor
      ≥27.8 mg/mL
  3. Mubritinib (TAK 165)
    B1543 Mubritinib (TAK 165)
    Target: ErbB
    Summary: Potent inhibitor of HER2/ErbB2
      insoluble in H2O; ≥76.9 mg/mL
  4. G-749
    A8889 G-749
    Target: Aurora Kinases|FLT3|c-RET
    Summary: FLT3 inhibitor
      ≥26.05 mg/mL
  5. Gefitinib hydrochloride
    A3433 Gefitinib hydrochloride
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; ≥4.28 mg/mL
  6. CUDC-101
    A4092 CUDC-101
     1 Citation
    Target: Histone Deacetylases (HDACs)|EGFR|ErbB
    Summary: Multitargeted HDAC inhibitor
      ≥21.7 mg/mL
  7. NVP-BHG712
    A8683 NVP-BHG712
    Target: Eph Receptors|VEGFR
    Summary: EphB4 inhibitor,potent and selective
      ≥25.15 mg/mL
  8. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: HER2 inhibitor,potent and selective
      ≥23.5 mg/mL
  9. AG-1478
    A8357 AG-1478
    Target: EGFR
    Summary: EGFR inhibitor,potent and selective
      insoluble in H2O; ≥15.8 mg/mL
  10. UNC2025
    B8016 UNC2025
     1 Citation
    Target: MER|FLT3
    Summary: orally bioavailable dual MER/FLT3 inhibitor
      ≥23.85 mg/mL

Items 31-40 of 97

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 7item
  2. Axl 4item
  3. ALK 3item
  4. c-FMS 1 item
  5. c-Kit 2item
  6. c-MET 9item
  7. c-RET 3item
  8. CSF-1R 2item
  9. EGFR 18item
  10. FAK 3item
  11. FGFR 4item
  12. FLT3 4item
  13. HER2 8item
  14. IGF1R 3item
  15. IRAK 2item
  16. ITK 1 item
  17. LRRK2 4item
  18. PDGFR 8item
  19. Pyk2 1 item
  20. Spleen Tyrosine Kinase (Syk) 3item
  21. Src 6item
  22. Tie-2 2item
  23. Trk 2item
  24. VEGFR 18item
Specificity
  1. Selective 59item
Reversibility
  1. Reversible 5item
  2. Irreversible 5item
Target
  1. Histone Deacetylases (HDACs) 1 item
  2. Raf 4item
  3. Aurora Kinases 2item
  4. CSF-1R 4item
  5. MER 1 item
  6. FLT3 9item
  7. Eph Receptors 1 item
  8. VEGFR 24item
  9. PDGFR 15item
  10. c-Kit 8item
  11. RET 1 item
  12. IRAK 2item
  13. Bcr-Abl 7item
  14. FGFR 8item
  15. MET 5item
  16. Src 8item
  17. Trk Receptors 2item
  18. STAT 1 item
  19. EGFR 17item
  20. FAK 3item
  21. JAK 2item
  22. Syk 3item
  23. ErbB 4item
  24. c-MET 6item
  25. PKC 1 item
  26. Lyn 1 item
  27. HER2 1 item
  28. Pyk2 2item
  29. LRRK2 4item
  30. Insulin and Insulin-like Receptors 3item
  31. ALK 3item
  32. Angiotensin-Converting Enzymes (ACEs) 1 item
  33. Tie-2 3item
  34. Ron 1 item
  35. 5-Lipoxygenases 1 item
  36. Insulin Receptors 1 item
  37. IRG-1R 1 item
  38. ZAP-70 1 item
  39. Flk-1 1 item
  40. c-RET 2item
  41. TAM kinase 1 item
  42. KDR 1 item
  43. Fyn kinase 1 item
  44. Abl kinases 1 item
  45. AXL 1 item
  46. c-Fms tyrosine kinase 1 item
  47. insulin 1 item
  48. Mer tyrosine kinase 1 item
  49. ErbB-2 1 item
  50. ITK 1 item
  51. DCLK2 1 item
  52. PTK 1 item
  53. Flk1 1 item
  54. YES 1 item
  55. Fyn 1 item
  56. enoyl-acyl-carrier protein reductase 1 item
  57. tropomyosin receptor kinase 1 item
  58. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Adrenocortical Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 12item
  7. Cancer 66item
  8. Cervical Cancer 1 item
  9. Cholangiocarcinoma 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 3item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 8item
  14. Glioblastoma 6item
  15. Glioma 1 item
  16. Hepatocellular Carcinoma 3item
  17. Leukemia 2item
  18. Liver Cancer 2item
  19. Lung Cancer 3item
  20. Lung Carcinoma 2item
  21. Lymphoma 4item
  22. Melanoma 1 item
  23. Multiple Myeloma 2item
  24. Non-small Cell Lung Cancer 3item
  25. Ovarian Cancer 5item
  26. Pancreatic Cancer 9item
  27. Prostate Cancer 5item
  28. Renal Cancer 1 item
  29. Renal Cell Carcinoma 1 item
  30. Rheumatoid Arthritis 2item
  31. Thyroid Cancer 2item